YY1 and prostate cancer: Interestingly, high expression of YY1 was also associated with a longer DFS in prostate cancer (Seligson et al. 2005) and a better outcome in pancreatic cancer (Zhang et al. 2014), colon cancer (Chinnappan et al. 2009) and follicular lymphoma (Naidoo et al. 2011).